• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

VitalWorks revenues drop

Article

IT provider VitalWorks, which last year acquired PACS vendor Amicas, reported a drop in revenues for the fourth quarter ended Dec. 31, compared with both the immediately preceding quarter and the same period a year earlier. The company tallied $26.7

IT provider VitalWorks, which last year acquired PACS vendor Amicas, reported a drop in revenues for the fourth quarter ended Dec. 31, compared with both the immediately preceding quarter and the same period a year earlier. The company tallied $26.7 million, compared with $28.1 million in the preceding quarter (end Sept. 30) and $29 million for the quarter ending Dec. 31, 2002. VitalWorks had a net loss of $2 million for 4Q 2003, compared with net income of $4.1 million for the corresponding 2002 period. On the bright side, deferred revenues rose to $11.8 million as of Dec. 31 from $7.9 million on Sept. 30. Company executives predicted that PACS will drive growth in radiology IT for the next several years, and that the combination of Amicas' PACS and its own radiology products will provide an advantage in this market.

Related Videos
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Assessing the Impact of Radiology Workforce Shortages in Rural Communities
Emerging MRI and PET Research Reveals Link Between Visceral Abdominal Fat and Early Signs of Alzheimer’s Disease
Reimbursement Challenges in Radiology: An Interview with Richard Heller, MD
Nina Kottler, MD, MS
The Executive Order on AI: Promising Development for Radiology or ‘HIPAA for AI’?
Related Content
© 2024 MJH Life Sciences

All rights reserved.